Devices › Pump, infusion, insulin
Device brand name · V-go
V-Go Disposable Insulin Delivery Device: medical device reports filed with FDA
2,101 reports name it, 2012–2026. Manufacturer given most often on reports: Valeritas. Product code LZG.
- 2,101
- device reports naming the brand
- 0% of all MAUDE reports · about 149 a year
- 14
- reports, 12 months to August 2026
- 45 in the 12 months before
- 75.5%
- classified as malfunction
- 81.6% across the product code
- 1%
- classified as death, as reported
- 22 reports · not verified by FDA
2,101 medical device reports received by FDA name the brand "V-Go Disposable Insulin Delivery Device" (v-go); the manufacturer given most often on reports is Valeritas; received from June 2012 to August 2026. Brand names are as the reporter or manufacturer wrote them, so one product can appear under several spellings.
14 reports arrived in the 12 months to August 2026, down 69% from 45 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (75.5%), injury (23.5%) and death (1%); across all pump, infusion, insulin reports (product code LZG) death is recorded in 0.3% and malfunction in 81.6%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are premature separation (34.2%), activation, positioning or separation problem (21.3%) and insufficient device problem information (12.7%). The patient problems coded most often are hyperglycemia, hypoglycemia and elevated ketones/ diabetic ketoacidosis. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 539,975 reports carrying product code LZG. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Premature separation | 719 | 34.2% | 0.1% |
| Activation, positioning or separation problem | 447 | 21.3% | 2% |
| Insufficient device problem information | 267 | 12.7% | 5% |
| Excess flow or over-infusion | 7 | 0.3% | 0.3% |
| Infusion or flow problema problem with flow or infusion | 6 | 0.3% | 0.2% |
| Insufficient flow or under infusion | 5 | 0.2% | 0.3% |
| Patient device interaction problem | 5 | 0.2% | 0.1% |
| Improper or incorrect procedure or method | 3 | 0.1% | 1.1% |
| Device operates differently than expectedthe device behaved unexpectedly | 2 | 0.1% | 4.7% |
| Fluid/blood leak | 2 | 0.1% | 2.2% |
| Detachment of device or device componentpart of the device came off | 1 | 0% | 0.2% |
| Device expiration issue | 1 | 0% | 0% |
| Failure to adhere or bond | 1 | 0% | 0.4% |
| Failure to prime | 1 | 0% | 2.7% |
| Inaccurate delivery | 1 | 0% | 1.7% |
| Loss of or failure to bond | 1 | 0% | 4.6% |
| Mechanical problema mechanical problem | 1 | 0% | 3.5% |
| Off-label use | 1 | 0% | 0% |
| Physical resistance/sticking | 1 | 0% | 0.1% |
| Separation failure | 1 | 0% | 0% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Hyperglycemiahigh blood sugar | 223 | 10.6% |
| Hypoglycemialow blood sugar | 182 | 8.7% |
| Elevated ketones/ diabetic ketoacidosis | 49 | 2.3% |
| Painpain, site not specified | 44 | 2.1% |
| Deaththe patient died; cause not stated by this term | 18 | 0.9% |
| Skin inflammation/ irritation | 13 | 0.6% |
| Needle stick/puncture | 8 | 0.4% |
| Discomfortdiscomfort | 7 | 0.3% |
| Confusion/ disorientation | 5 | 0.2% |
| Nauseafeeling sick | 5 | 0.2% |
| Vomitingbeing sick | 5 | 0.2% |
| Abrasion | 4 | 0.2% |
| Cellulitisa skin infection | 4 | 0.2% |
| Headachehead pain | 4 | 0.2% |
| Loss of consciousnesspassing out | 4 | 0.2% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | V-Go Disposable Insulin Delivery Device | Product code LZG | All MAUDE reports |
|---|---|---|---|
| Reports | 2,101 | 539,975 | 26,136,888 |
| Share of that pool | — | 0.4% | 0% |
| Classified as death, per 1,000 reports | 10 | 3 | 9 |
| Classified as injury | 23.5% | 17.8% | 36.2% |
| Classified as malfunction | 75.5% | 81.6% | 62.3% |
| Filed by the manufacturer | 100% | 99.8% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code LZG
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| Onetouchping Glucosemgmtsystem | 98,945 | 0 | 0.1% |
| Omnipod DASH Insulin Management System | 62,646 | 5,563 | 0.1% |
| Tandem T Slim Insulin Delivery System | 55,207 | 0 | 0.1% |
| OmniPod Insulin Pump | 45,272 | 145 | 0.3% |
| Omnipod Insulin Management System | 37,582 | 218 | 0.1% |
| Animas Vibe | 88,703 | 0 | 0% |
| Animas Insulin Infusion Pump | 26,293 | 0 | 0.3% |
| MMT-712 PARADIGM Insulin Pump | 25,781 | 4,138 | 0% |
| Accu-Chek Spirit Combo | 21,252 | 0 | 0.1% |
| t:slim Insulin Delivery System | 19,277 | 30 | 0.1% |
| t:slim X2 Insulin Pump | 31,159 | 86 | 0% |
| Animas Insulin Cartridge | 12,105 | 0 | 0% |
| T Flex Insulin Delivery System | 11,359 | 0 | 0.1% |
| Paradigm Insulin Infusion Pump | 16,324 | 0 | 0.4% |
| Accu-Chek Spirit | 8,826 | 0 | 0.3% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about V-Go Disposable Insulin Delivery Device reports
How many FDA reports name V-Go Disposable Insulin Delivery Device?
2,101 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 14 in the latest 12 months.
What kinds of events are reported?
malfunction (75.5%), injury (23.5%) and death (1%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
premature separation (34.2%), activation, positioning or separation problem (21.3%), insufficient device problem information (12.7%), excess flow or over-infusion (0.3%) and infusion or flow problem (0.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that V-Go Disposable Insulin Delivery Device was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.